MEK inhibitors induce Akt activation and drug resistance by suppressing negative feedback ERK‐mediated HER2 phosphorylation at Thr701

Targeting the MEK/ERK pathway has been viewed as a promising strategy for cancer therapy. However, MEK inhibition leads to the compensatory PI3K/AKT activation and thus contributes to the desensitization of cancer cells to MEK inhibitors. The underlying molecular mechanism of this event is not yet u...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Chia‐Hung, Hsia, Te‐Chun, Yeh, Ming‐Hsin, Chen, Tsung‐Wei, Chen, Yun‐Ju, Chen, Jung‐Tsu, Wei, Ya‐Ling, Tu, Chih‐Yen, Huang, Wei‐Chien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5579385/
https://www.ncbi.nlm.nih.gov/pubmed/28632938
http://dx.doi.org/10.1002/1878-0261.12102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5579385/
https://www.ncbi.nlm.nih.gov/pubmed/28632938
http://dx.doi.org/10.1002/1878-0261.12102

Ejemplares similares